The cobas 6800 and 8800 systems are fully automated molecular platforms used to screen blood and plasma for various traits.
The new cobas MPX test detects HIV-1 and HIV-2, hepatitis B virus and hepatitis C virus in blood donations.
More articles on supply chain:
FDA warns hospitals about St. Louis devicemaker selling unapproved devices
The new Mylan? Senators call out Ariad for high price of leukemia drug
Medical device execs call for quicker coverage decisions from CMS
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.